
Ferroptosis Triggers PGE2 Release, Blocking T-Cell Immunity in Cancer
A study in Nature reveals that ferroptosis, a form of cell death used to treat resistant cancers, inadvertently triggers the production of prostaglandin E2 (PGE2). This chemical suppresses the immune system, allowing tumours to escape destruction.